Perspective Therapeutics (CATX) Operating Leases (2019 - 2026)

Perspective Therapeutics has disclosed Operating Leases across 8 years of filings, most recently posting $1.6 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $1.6 million, up 32.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 32.2% YoY), and the FY2025 annual result was $1.0 million, down 29.62% from the prior year.
• Operating Leases came in at $1.6 million for Q1 2026 at Perspective Therapeutics, up from $1.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.7 million in Q3 2024 to a low of $44000.0 in Q1 2023.
• The 5-year median for Operating Leases is $1.0 million (2024), against an average of $941625.0.
• Across the five-year window, Operating Leases tumbled 86.42% in 2023 and jumped 2256.82% in 2024, its largest moves.
• Perspective Therapeutics' Operating Leases stood at $186000.0 in 2022, then surged by 319.35% to $780000.0 in 2023, then surged by 83.08% to $1.4 million in 2024, then dropped by 29.62% to $1.0 million in 2025, then soared by 54.43% to $1.6 million in 2026.
• The last three Operating Leases figures came in at $1.6 million (Q1 2026), $1.0 million (Q4 2025), and $971000.0 (Q3 2025), per Business Quant data.